Guaifenesin Tablet, Extended Release
Product Images NDC 58602-865

1 FDA label image from Aurohealth Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 58602-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (42 (3 x 14) Tablets))

Package Label-principal Display Panel (1200 mg Blister Carton (42 (3 x 14) Tablets))
Guaifenesin 1200 mg Extended-Release Tablets packaging label by Aurohealth LLC. The label indicates 42 tablets, labeled as maximum strength expectorant, designed to relieve chest congestion and loosen mucus. The product is valid for oral use and displays a 12-hour extended-release feature. The label includes directions, warnings, inactive ingredients, and contact information for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.